Literature DB >> 19839222

Antimicrobial pomegranate rind extracts: enhancement by Cu(II) and vitamin C combinations against clinical isolates of Pseudomonas aeruginosa.

S W J Gould1, M D Fielder, A F Kelly, W El Sankary, D P Naughton.   

Abstract

Recently, natural products have been further evaluated as sources of antimicrobial agents with efficacies against a variety of microorganisms. This study reports the antimicrobial activities of pomegranate rind extract (PRE) in combination with Fe(II) and Cu(II) salts against extended-spectrum multidrug-resistant Pseudomonas aeruginosa. Antimicrobial suspension assays were carried out using aqueous extract of pomegranate alone or in combination with metals salts against P. aeruginosa. The extract:metal salt combination was also enhanced with the addition of vitamin C. Marked activities were observed for the aqueous PRE/Cu(II) preparations, which were greatly enhanced by the addition of the reductant vitamin C. In contrast, the aqueous PRE/Fe(II) preparations were inactive, regardless of addition of vitamin C. The combination of PRE and Cu(II) salts and vitamin C showed the greatest activity against clinical isolates of P. aeruginosa. These results warrant further investigation of PRE as a potential source of new antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839222     DOI: 10.1080/09674845.2009.11730258

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  2 in total

1.  Enhancement of antimicrobial activities of whole and sub-fractionated white tea by addition of copper (II) sulphate and vitamin C against Staphylococcus aureus; a mechanistic approach.

Authors:  Andrew C Holloway; Simon W J Gould; Mark D Fielder; Declan P Naughton; Alison F Kelly
Journal:  BMC Complement Altern Med       Date:  2011-11-17       Impact factor: 3.659

2.  Protective Effects of Vitamin C and NAC on the Toxicity of Rifampin on Hepg2 Cells.

Authors:  Nasser Vahdati-Mashhadian; Mahmoud Reza Jafari; Nasim Sharghi; Toktam Sanati
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.